Search arXiv⌕ Search

arXiv · 2610.14974

Ensemble-Based Modelling of Optogenetic Bioprocesses under Phototoxicity

Abstract

Optogenetics enables methanol-free protein production in the yeast $\textit{Komagataella phaffii}$ using light as a control input, facilitated by the blue-light-responsive transcription factor EL222. This opens the door to more programmable protein production in the food and biopharmaceutical industries. However, excessive illumination can inhibit growth and protein accumulation in some of these engineered cell factories. Previous hybrid modelling used black-box regression across sparsely sampled conditions to infer light-dependent kinetic parameters, without explicitly representing intracellular regulation. Here, we develop a multiscale mechanistic model linking EL222 activation, transcription, and translation to protein, biomass, and substrate dynamics. A latent light-associated stress state represents photoinhibitory effects on growth, transcription, and translation. An ensemble-based parameter-estimation strategy combines repeated global-local optimisation with screening for parameter sets supporting locally stable intracellular steady states under specified light conditions. Using available batch data for yeast-enhanced green fluorescent protein production in a $\textit{K. phaffii}$ strain carrying eight EL222 gene copies, the ensemble-mean predictions captured the main experimental trends in protein accumulation and growth across six constant light intensities. Parameter variability was propagated to time-course predictions, providing an empirical assessment of parameter-related uncertainty. Wider prediction bands coincided with less complete experimental coverage of the growth phases. Overall, the framework provides a mechanistic basis for future model-based optimisation and control of optogenetic bioprocesses under phototoxicity.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Yufan Liu, Sam Ferrer, Sebastián Espinel-Ríos. 2026-10-10. Ensemble-Based Modelling of Optogenetic Bioprocesses under Phototoxicity. https://arxiv.org/abs/2610.14974

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

An efficient and flexible generalization of transit compartment models for delayed biological processes

Transit compartment models are widely used in pharmacokinetics/pharmacodynamics to represent delayed biological processes such as absorption, maturation, cellular proliferation, and treatment-induced toxicity. This transit compartment formulation imposes an artificial relationship between the mean and variance of the delay distribution, as the number of transit compartment must be integer-valued number of transit compartments. Consequently, estimating the number of compartments from experimental data leads to mixed-integer optimization problems that artificially constrain model dynamics and bias parameter inference. However, these transit compartment models are mathematically equivalent to distributed delay differential equations with Erlang delay kernels. We leverage a hypoexponential generalization of these distributed delay differential equations that preserves the familiar ordinary differential equation structure while allowing the mean and variance of the delay distribution to be estimated directly as real-valued parameters. This approach does not increase the number of inferred parameters and can be immediately implemented as a straightforward modification of existing transit compartment models. We demonstrate the approach using models of viral eclipse phases, lymphocyte proliferation, and chemotherapy-induced neutropenia. Across these examples, the hypoexponential formulation provides comparable or improved fits relative to Erlang transit models and substantially reduces computational cost by avoiding grid search over compartment numbers. This framework provides a practical approach to estimate biologically meaningful delay distributions in quantitative systems pharmacology (QSP) models.

q-bio.QM↗

STAMP as a topology-aware molecular language for fragment-level learning and editing

Molecular fragments provide chemically meaningful units, but existing molecular languages rarely make their locations and connections explicit for editing. Here we introduce STAMP (Sequential Tree Attachment-based Motif-Preserving representation), a topology-aware molecular language that connects fragment-level representation learning with precise structural editing. STAMP separately encodes motif identity, attachment sites and tree topology, making fragments reusable across contexts and subtrees directly accessible. Learned representations capture motif similarity and recurring transformations, and lower activity-cliff prediction error on 23 of 30 targets versus a matched SMILES encoder. Compatible subtree operations support scaffold-preserving optimization, ranking first among six methods on 15 of 23 benchmark objectives. A deterministic compiler enables frozen language models to act on indexed fragments, improving molecular editing, optimization, transformation transfer and change identification by 9 to 56 percentage points over plain SMILES. Together, these results establish an executable molecular language in which learned chemical units remain directly operable during design.

q-bio.QM↗

Brain Age Gap Progression in Individuals at Risk for Neurodegeneration

Neuroimaging is a widely used modality for characterizing neurodegeneration in various health conditions. Brain age gap has emerged as a promising biomarker for monitoring brain health from neuroimaging data using machine learning algorithms. Recent studies have leveraged coVariance neural networks (VNN)-driven pipelines based on the advancements in graph signal processing for relatively transparent construction of brain age gap from neuroimaging data. In this paper, we focus on a longitudinal study of VNN-based brain age gap in conjunction with Alzheimer's Progression Score (APS) in individuals that are at a higher risk of neurodegeneration due to family history of Alzheimer's disease. APS is a multimodal marker of disease progression. The longitudinal analysis of APS and VNN-derived brain age gap metrics revealed that a higher risk of disease progression at baseline predicted a larger rate of increase in brain age gap in follow-up visits. Thus, our findings revealed potential stratification in the brain age gap modulated by clinical/biological risks of AD in the at-risk population.

q-bio.QM↗